(Q80447239)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15309501%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

The effect of infliximab on extraintestinal manifestations of Crohn's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15309501%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

Iris Dotan

4

0 references

Ori Elkayam

object named as

Ori Elkayam

6

0 references

author name string

Ilana Kaufman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15309501%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Dan Caspi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15309501%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Dror Yeshurun

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15309501%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Michael Yaron

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15309501%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

12 August 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15309501%20AND%20SRC:MED&resulttype=core&format=json

Rheumatology International

31 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15309501%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15309501%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15309501%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

406-410

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15309501%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00296-004-0467-8

31 December 2019

exact match

0 references

cites work

Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study

1 reference

12 December 2020

Immunotherapy for rheumatoid arthritis

1 reference

12 December 2020

Therapeutic advances in ankylosing spondylitis

1 reference

12 December 2020

Measuring Crohn's disease activity

1 reference

12 December 2020

The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study

1 reference

12 December 2020

Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial

1 reference

12 December 2020

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

1 reference

12 December 2020

Scintigraphic evidence of effect of infliximab on disease activity in ankylosing spondylitis

1 reference

12 December 2020

The Crohn's Disease Activity Index, its derivatives and the Inflammatory Bowel Disease Questionnaire: a review of instruments to assess Crohn's disease

1 reference

12 December 2020

Immunomodulatory effects of anti-tumor necrosis factor alpha therapy on synovium in spondylarthropathy: histologic findings in eight patients from an open-label pilot study

1 reference

12 December 2020

Infliximab in ankylosing spondylitis: a prospective observational inception cohort analysis of efficacy and safety

1 reference

12 December 2020

Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha

1 reference

12 December 2020

Review article: targeting TNF alpha as a key cytokine in the inflammatory processes of Crohn's disease--the mechanisms of action of infliximab

1 reference

12 December 2020

Eye and spondylarthropathies

1 reference

12 December 2020

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

1 reference

12 December 2020

Infliximab for the treatment of fistulas in patients with Crohn's disease

1 reference

12 December 2020

Clinical and imaging correlates of response to treatment with infliximab in patients with ankylosing spondylitis

1 reference

12 December 2020

1 reference

12 December 2020

Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab

1 reference

12 December 2020

Crohn's disease arthritis treated with infliximab: an open trial in four patients

1 reference

12 December 2020

Current use of biologicals for the treatment of spondyloarthropathies

1 reference

12 December 2020

Successful short term treatment of severe undifferentiated spondyloarthropathy with the anti-tumor necrosis factor-alpha monoclonal antibody infliximab.

1 reference

12 December 2020

Musculoskeletal Manifestations in a Population-based Cohort of Inflammatory Bowel Disease Patients

1 reference

12 December 2020

Clinical features and treatment of peristomal pyoderma gangrenosum

1 reference

12 December 2020

The prevalence and incidence of peripheral arthritis in patients with inflammatory bowel disease, a prospective population-based study (the IBSEN study).

1 reference

12 December 2020

[Hematologic aspects of inflammatory bowel diseases]

1 reference

12 December 2020

Improvement of Pyoderma gangrenosum and psoriasis associated with Crohn disease with anti-tumor necrosis factor alpha monoclonal antibody.

1 reference

12 December 2020

Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: the first 100 patients

1 reference

12 December 2020